CLOUDED LEOPARD (NEOFELIS NEBULOSA) MORBIDITY AND MORTALITY IN CAPTIVE-BRED POPULATIONS: A COMPREHENSIVE RETROSPECTIVE STUDY OF MEDICAL DATA FROM 271 INDIVIDUALS IN EUROPEAN, ASIAN, AND AUSTRALIAN ZOOS.

The clouded leopard (Neofelis nebulosa) is classified as vulnerable on the International Union for the Conservation of Nature Red List of Threatened Species. However, diseases affecting this species across zoo populations are not well documented. The primary objective of this retrospective study was to identify common and significant causes of morbidity and mortality in captive-bred clouded leopards from European, Asian, and Australian institutions. Medical records from 44 zoological parks that held 271 clouded leopards from 1934 to 2017 were reviewed. Major causes of mortality in the dead leopards (n = 141) were respiratory disease (17%), maternal neglect and starvation (12%), generalized infectious disease (10%), digestive disease (10%), and trauma (10%). Six animals lived more than 20 yr and two were older than 22 yr. Diseases were recorded 344 times (average of two per leopard) in 166 living leopards. The body systems most frequently affected by disease in these 166 individuals were, in order of frequency, integumentary (prevalence = 21%), digestive (21%), respiratory (16%), musculoskeletal (12%), and urinary (10%) systems. Neoplasia (7%) was less frequent, followed by cardiovascular (5%), genital (3%), and viral (3%) disorders. Extensive, self-induced alopecia on the tail and dorsum was the most frequently reported dermatological disease, which is proposed to be called the "clouded leopard alopecia syndrome." The most common neoplasm was pheochromocytoma (1%), followed by squamous cell carcinoma of the paw pads, pleural mesothelioma and multicentric lymphomas (<1% each). Dilated cardiomyopathy (2%) was the most common cardiovascular disease. Bronchopneumonia (7%), enteritis (4%), and nephritis (4%) were the most frequently reported respiratory, digestive, and renal diseases, respectively. Diagnosed disease incidence was significantly higher in Europe. This paper reports the results of a comprehensive study of the causes of morbidity and mortality in European, Asian, and Australian clouded leopard zoo populations.

RETROSPECTIVE STUDY OF CAUSES OF ANIMAL MORTALITY IN LJUBLJANA ZOO 2005-2015.

Zoos harbor large collections of diverse species, aiding in both conservation and education, as well as research in multiple scientific fields. However, the most common causes of death in zoo animals around the world remain unclear because few extensive reports or reviews are published on this topic. This information could greatly improve preventive veterinary medicine in zoologic gardens. This study provides a retrospective overview of the causes of death of animals from the Ljubljana Zoo in the years 2005-2015. During this period, a total of 353 animals were submitted for necropsy, of which 244 were mammals, 85 were birds, and 25 were reptiles. The causes of deaths were divided into infectious diseases (38%), dysfunctions of individual organs (20%), traumas (13%), parasitosis (7%), reproductive disorders (6%), metabolic disorders (3%), neoplastic disease (4%), and intoxications (4%). In some cases, the cause of death was unable to be determined (7%), most commonly because of autolysis of the body. The results of this retrospective study bring a general overview of the epizootiologic situation in the Ljubljana Zoo over an 11-yr period and valuable information to other zoos to optimize preventative plans and diagnostics.

'We shouldn't classify pet obesity as a disease'.

Robin Hargreaves argues that the chronic weight gain that leads to obesity in pets is a normal animal behaviour and physiological mechanism, and so should not be regarded as a disease process.

What is behind phylogenetic analysis of hospital-, community- and livestock-associated methicillin-resistant Staphylococcus aureus?

Methicillin-resistant Staphylococcus aureus (MRSA) has been shown to be the predominant life-threatening pathogen in Egypt. MRSA is a major cause of severe healthcare-associated (HA) infections. During the last decades, the incidence of community-associated (CA) MRSA infections has a complex epidemiology arising from the circulation of different strains in the general population. Moreover, livestock-associated (LA) MRSA emerged recently becomes an emerging threat to public health. Therefore, it is important to illuminate the differences between CA-, HA- and LA-MRSA to shed light on their genetic diversity and evolution. This study presents the first data on analysing the correlation between CA-, LA- and HA-MRSA using antibiogram typing, molecular characteristics and antimicrobial resistance and virulence genes' profiles. Overall, HA-MRSA strains tended to be multidrug resistant and less virulent than both LA- and CA-MRSA strains. Importantly, CA-MRSA strains had a high homology with each of HA- and LA-MRSA. However, no similarity was observed between HA- and LA-MRSA. Our findings suggest that the epidemiological changes in genetic behaviour between HA- and LA-MRSA are due to the presence of CA-MRSA confirming that CA-MRSA has created a public health crisis worldwide.

The economic impact of a new animal disease: same effects in developed and developing countries?

Animal disease outbreaks generate a range of economic and non-economic impacts. While a significant number of research studies have estimated the effects of various diseases in a variety of contexts, examining the differential impacts and implications associated with the introduction of a novel disease into a developing country, as opposed to a developed one, is a rich area for further research. In this paper, the authors highlight some of the key dimensions and implications associated with the impacts of new diseases, how they differ in different contexts, and their implications for public policy.

La survenue de foyers de maladies animales entraîne des effets divers, de nature économique et non économique. Si l'estimation de l'impact de nombreuses maladies dans différents contextes a fait l'objet de très nombreuses études, l'évaluation différentielle de l'impact de l'introduction d'une maladie nouvelle dans un pays en développement et de ses conséquences, par opposition à ce qu'ils seraient dans un pays développé, constitue un domaine de recherche au riche potentiel largement inexploré. Les auteurs mettent en avant les dimensions et conséquences majeures de l'impact des maladies nouvelles et en soulignent les spécificités selon les contextes ainsi que leurs conséquences en termes de politiques publiques.

Los brotes de enfermedades animales traen consigo una serie de consecuencias de orden económico y no económico. Si bien ha habido numerosas investigaciones destinadas a evaluar los efectos de varias enfermedades en distintos contextos, el estudio del impacto y las repercusiones diferenciales que se siguen de la introducción de una nueva enfermedad en un país en desarrollo, por oposición a un país desarrollado, constituye un prometedor ámbito de investigación para el futuro. Los autores destacan algunas de las principales dimensiones y repercusiones ligadas a las consecuencias de nuevas enfermedades y examinan cómo difieren en función del contexto y cómo repercuten en las políticas públicas.

Classification and management of animal anthrax outbreaks based on the source of infection.

Anthrax is a non-contagious infectious disease; it primarily affects herbivores, but all mammals, including humans, can be affected. Humans may contract anthrax directly or indirectly from infected animals. Veterinary surveillance systems, providing information about animal and human cases, should increase the efficacy of the animal anthrax management in order to protect population. Any aspect of the disease should be carefully monitored to implement effective prevention and control strategies. In this paper we propose a new, detailed classification of anthrax outbreaks, based on the source of the infection and the risk level for humans. We describe three different types of animal outbreaks and suggest the most effective procedures for their management and prevention.

Toward a modernized definition of wildlife health.

There has been, to date, little discussion about the defining features and measures of wildlife health in the literature or legislation. Much wildlife health work focuses on the detection and response to infectious or parasitic diseases; this perspective has been reinforced by the focus of the One Health initiative on wildlife as sources of emerging infections. The definition of health as "the absence of disease" lags 70 yr behind modern concepts of human health and emerging concepts of wildlife health in terms of vulnerability, resilience, and sustainability. Policies, programs, and research that focus on the integration of wildlife health with natural resource conservation, ecosystem restoration, and public health need a working definition of health that recognizes the major threats to fish and wildlife are the result of many other drivers besides pathogens and parasites, including habitat loss, globalization of trade, land-use pressure, and climate change. A modern definition of wildlife health should emphasize that 1) health is the result of interacting biologic, social, and environmental determinants that interact to affect capacity to cope with change; 2) health cannot be measured solely by what is absent but rather by characteristics of the animals and their ecosystem that affect their vulnerability and resilience; and 3) wildlife health is not a biologic state but rather a dynamic social construct based on human expectations and knowledge.

[Economic management of health crises affecting production animals in Europe]. / Instruments de gestion economique des crises sanitaires touchant les animaux de production en Europe.

The importance of animal health crises has considerably increased over the last few years. When a crisis occurs, farmers can receive financial support through various public, private and mixed compensation schemes. Economic losses resulting from diseases may be direct and indirect. If a disease is covered by European Union regulations then countries have a legal obligation to partly compensate farmers for direct losses, either directly through the national budget, or through a specific fund. The European Veterinary Fund also co-finances these losses. Only a few countries provide compensation for indirect losses. The private insurance sector also provides protection against some direct and indirect losses but the risks covered are variable. To encourage farmers to subscribe to this kind of insurance, some public authorities provide subsidies to help pay the premium. Insurance companies do not generally cover the risks linked to contagious diseases, but some companies do extend cover to include this type of risk. Several alternatives, such as mutual funds, are available to improve risk coverage. There is a lack of harmonisation among the various compensation schemes of different countries. Public authorities cannot provide full compensation, but mutual funds and private insurance companies are alternatives that should be further investigated and their use should be extended to other countries. A classification of diseases would harmonise the situation at the European level.

Methodology of the biological risk classification of animal pathogens in Belgium.

Since many micro-organisms are a biological hazard, they have been categorised into risk groups by many countries and organisations and classification lists have been developed. Current classification systems rely on criteria defined by the World Health Organization, which cover the severity of the disease the micro-organism might cause, its ability to spread and the availability of prophylaxis or efficient treatment. Animal pathogens are classified according to the definitions of the World Organisation for Animal Health, which also consider economic aspects of disease. In Europe, classification is often directly linked to containment measures. The Belgian classification system, however, only considers the inherent characteristics of the micro-organism, not its use, making the risk classification independent of containment measures. A common classification list for human and animal pathogens has been developed in Belgium using as comprehensive an approach as possible. The evolution of scientific knowledge will demand regular updating of classification lists. This paper describes the Belgian risk classification system and the methodology that was used for its peer-reviewed revision (with a focus on animal pathogens).

Postmortem diagnostic investigation of disease in free-ranging marine turtle populations: a review of common pathologic findings and protocols.

Over the past few decades, there have been increasing numbers of reports of diseases in marine turtles. Furthermore, in recent years, there have been documented instances of apparently new diseases emerging in these species of which the etiology and/or pathogenesis remain unknown. These instances i) raise concern for the survival of marine turtles, and ii) question the health and stability of the benthic marine environments in which turtles live. Knowledge of common disease processes and pathologic changes in lesions, along with a standardized approach to postmortem and sample collection are required to document and understand the host-agent-environment interactions in marine turtle health. This review combines, for the first time, a standardized approach to the postmortem of marine turtles for veterinary clinicians, with a concurrent descriptive review of the gross and microscopic pathologic changes in lesions commonly seen.

Aquatic eutrophication promotes pathogenic infection in amphibians.

The widespread emergence of human and wildlife diseases has challenged ecologists to understand how large-scale agents of environmental change affect host-pathogen interactions. Accelerated eutrophication of aquatic ecosystems owing to nitrogen and phosphorus enrichment is a pervasive form of environmental change that has been implicated in the emergence of diseases through direct and indirect pathways. We provide experimental evidence linking eutrophication and disease in a multihost parasite system. The trematode parasite Ribeiroia ondatrae sequentially infects birds, snails, and amphibian larvae, frequently causing severe limb deformities and mortality. Eutrophication has been implicated in the emergence of this parasite, but definitive evidence, as well as a mechanistic understanding, have been lacking until now. We show that the effects of eutrophication cascade through the parasite life cycle to promote algal production, the density of snail hosts, and, ultimately, the intensity of infection in amphibians. Infection also negatively affected the survival of developing amphibians. Mechanistically, eutrophication promoted amphibian disease through two distinctive pathways: by increasing the density of infected snail hosts and by enhancing per-snail production of infectious parasites. Given forecasted increases in global eutrophication, amphibian extinctions, and similarities between Ribeiroia and important human and wildlife pathogens, our results have broad epidemiological and ecological significance.

Control and eradication of O.I.E. list A diseases--the approach of the European Union to the use of vaccines.

In the last decade the European Union has experienced serious outbreaks of certain O.I.E. list A diseases such as foot-and-mouth disease, classical swine fever and avian influenza. These diseases have been controlled and eradicated by means of culling and destroying a very large number of animals, which has been very expensive and has raised ethical questions. In accordance with existing rules, emergency vaccination has also been applied under certain circumstances, but its use has often been hampered by the impossibility of distinguishing vaccinated but healthy animals from the infected ones and by its negative impact on the trade of the vaccinated animals and their products. Marker vaccines and suitable accompanying discriminatory tests may overcome these problems and be used as additional eradication tools, where appropriate. Provisions on the use of these tools have already been introduced in the legislation of the European Union.

Wildlife veterinarian, conservation and public health.

In recent years wildlife diseases (infectious and non-infectious) have played a relevant role in both wildlife conservation and public health. Global environmental changes have determined a bimodal evolution of wildlife. On one side a huge loss of biodiversity has been observed leading to the increasing of threatened or endangered species. In contrast few opportunistic taxa increased their aboundances and ranges. The above scenarios claim the intervention of wildlife veterinarians. In conservation the understanding of the ecological role of the host parasite relationship and the perturbations on the host population dynamics have to be assessed and eventually modified. In public health the increased overlapping among wildlife, livestock, pets and human beings represents a risk for diseases spread (no matter in which directions). Serious limits are, still now, observed in the acceptance of this 'new world' by veterinary academics. As a consequence curricula often fail in providing adequate skill at both undergraduate and graduate levels. An addressed approach towards wildlife diseases should be promoted as an essential component of environmental management.

Construct models in veterinary behavioural medicine: lessons from the human experience.

Veterinary behavioural medicine is marked by inconsistency in the naming and description of animal behavioural disorders, potentially hindering research and reducing the clinical utility of diagnoses. Sources of diagnostic inconsistency are suggested and parallels with human psychiatry are identified. This paper questions the use of categorical models as the basis for classification and reviews criticisms of categorical approaches in psychiatry. Evidence is presented to suggest an inconsistency between discrete categories and the structure of animal behavioural disorders. The potential benefits of exploring alternative models are discussed. It is concluded that it is important to move away from an approach based on advocacy and towards objective assessment of all available data. Existing diagnoses should be viewed as hypothetical constructs, with the underlying hypotheses being identified and subject to investigation. It is emphasized that global communication, empirical investigations and critical review are necessary for the development of a solid scientific basis within veterinary behavioural medicine.